Noroviruses are known to bind to histo-blood group antigens (HBGAs) and the specific binding patterns depend on the virus genotype. However, the development of point-of-care diagnostic assays based on this binding has been challenging due to low assay sensitivity. This study utilized a well-defined stool collection from a GII.2 Snow Mountain Virus (SMV) human challenge study to investigate virus recovery from stool and emesis samples using HBGA-coated beads. SMV was recovered from H type III-coated beads for 13 stool specimens out of 27 SMV-positive specimens tested. After adjusting for non-specific binding to PEG-coated beads, the mean percent recovery by H type III-coated beads was 308.11% +/− 861.61. Recovery by H type III ligands was subject-specific and weakly correlated with stool consistency. input virus titer was not correlated with SMV recovery. the results suggest that the generally low virus recovery we observed may be due to bead saturation or hindrance by existing glycans in the matrix that precluded the virus from being captured by the synthetic glycans. These results indicate a strong role for subject-specific and matrix effects in HBGA binding by SMV. Further investigation of the nature of this interference is needed to facilitate development of high sensitivity diagnostic assays.Noroviruses are a major cause of gastroenteritis worldwide in all age groups 1 . In the United States, it is estimated to cause 58% of all foodborne illnesses 2 . The illness is generally limited and resolves without medical intervention, however, severe outcomes and deaths do occur 3 . Three norovirus genogroups are known to cause illness in humans: GI, GII, and GIV. GII viruses are the most common, specifically GII.4, which is the genotype responsible for cyclic norovirus pandemics 4 . In vitro studies have shown that noroviruses bind to histo-blood group antigens (HBGAs), which comprise the ABO, Lewis, and secretor phenotypes 5 . HBGAs are thought to be the primary receptors for the virus, and the pattern of binding to specific HBGAs varies by genotype.In clinical practice, norovirus illness is generally diagnosed without a laboratory test due to the lack of clinically useful diagnostics 6 . The gold standard diagnostic is reverse transcription-polymerase chain reaction (RT-PCR), which detects the viral RNA. For accurate genotype identification, RT-PCR is followed by amplicon sequencing. While RT-PCR is sensitive and specific, the fairly long turnaround time limits its utility for an illness where duration is measured in hours. Other antibody-based diagnostics are available, but their sensitivities are much lower than RT-PCR. Currently, there exists an unmet need to develop point of care diagnostics to detect norovirus in a variety of settings as early detection and isolation of the infected person would decrease the spread of the virus.Until recently, noroviruses could not be cultured in the laboratory 7 , which limited diagnostic development to the use of recombinant capsid protein that formed virus-like particles (V...